Global Drug Discovery Software market valued at ~$2 billion in 2020 and is projected to grow at a CAGR of ~14% to cross $3.5 billion by 2025
Driven by increased global R&D investment, the requirement for cost-efficiency and faster time-to-market, rigorous regulatory compliance/reporting, the expanding usage of AI and ML in drug development, and the rising need for unique software solutions especially developed for biologics, cell, and gene therapy. The life science industry is rapidly evolving and is increasingly looking for software solutions […]
Continue Reading